Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marathon Petroleum
MPC
|
+$152M |
| 2 |
AT&T
T
|
+$119M |
| 3 |
Norfolk Southern
NSC
|
+$117M |
| 4 |
CSX Corp
CSX
|
+$115M |
| 5 |
Booking.com
BKNG
|
+$104M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$187M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$156M |
| 3 |
C.H. Robinson
CHRW
|
+$134M |
| 4 |
PARA
Paramount Global Class B
PARA
|
+$130M |
| 5 |
BCR
CR Bard Inc.
BCR
|
+$100M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 18.4% |
| 2 | Industrials | 9.75% |
| 3 | Financials | 7.9% |
| 4 | Consumer Staples | 7.89% |
| 5 | Healthcare | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Humana
HUM
$46.4B
| $377K | ﹤0.01% |
+2,060
| New | +$357K |
|
|
BBG
952
DELISTED
Bill Barrett Corp
BBG
| $372K | ﹤0.01% |
+59,870
| New | +$240K |
|
|
UNT
953
DELISTED
UNIT Corporation
UNT
| $371K | ﹤0.01% |
42,150
+27,850
| +195% | +$238K |
|
|
PRXL
954
DELISTED
Parexel International Corp
PRXL
| $370K | ﹤0.01% |
+5,906
| New | +$364K |
|
955
Domino's
DPZ
$11.5B
| $368K | ﹤0.01% |
2,790
-21,905
| -89% | -$2.61M |
|
|
EXPR
956
DELISTED
Express, Inc.
EXPR
| $365K | ﹤0.01% |
854
-34,051
| -98% | -$12.2M |
|
|
IMMU
957
CALL
DELISTED
Immunomedics Inc
IMMU
| $365K | ﹤0.01% |
145,800
-1,172,700
| -89% | -$2.64M |
|
|
RGC
958
DELISTED
Regal Entertainment Group
RGC
| $364K | ﹤0.01% |
17,240
-25,870
| -60% | -$493K |
|
|
SYNH
959
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $363K | ﹤0.01% |
8,815
-15,360
| -64% | -$633K |
|
960
Kearny Financial
KRNY
$618M
| $362K | ﹤0.01% |
29,350
+16,630
| +131% | +$200K |
|
961
Cooper-Standard Automotive
CPS
$471M
| $361K | ﹤0.01% |
5,020
-7,140
| -59% | -$507K |
|
|
CSGS
962
DELISTED
CSG Systems International
CSGS
| $360K | ﹤0.01% |
7,980
+1,268
| +19% | +$47.8K |
|
963
Spok Holdings
SPOK
$222M
| $360K | ﹤0.01% |
+20,550
| New | +$350K |
|
964
Progressive
PGR
$130B
| $357K | ﹤0.01% |
+10,150
| New | +$324K |
|
965
Belden
BDC
$4.56B
| $356K | ﹤0.01% |
+5,800
| New | +$286K |
|
966
Enbridge
ENB
$109B
| $352K | ﹤0.01% |
+9,047
| New | +$309K |
|
|
GNC
967
DELISTED
GNC Holdings, Inc.
GNC
| $352K | ﹤0.01% |
+11,072
| New | +$317K |
|
|
CHK
968
DELISTED
Chesapeake Energy Corporation
CHK
| $348K | ﹤0.01% |
+422
| New | +$299K |
|
969
Air Products & Chemicals
APD
$68.2B
| $346K | ﹤0.01% |
+2,600
| New | +$314K |
|
970
Jacobs Solutions
J
$17.7B
| $346K | ﹤0.01% |
+9,611
| New | +$314K |
|
971
Mercer International
MERC
$26.9M
| $346K | ﹤0.01% |
36,585
+22,527
| +160% | +$182K |
|
|
SP
972
DELISTED
SP Plus Corporation
SP
| $345K | ﹤0.01% |
14,341
+5,321
| +59% | +$123K |
|
973
United Rentals
URI
$67.4B
| $344K | ﹤0.01% |
5,530
-739,298
| -99% | -$41.1M |
|
|
EGL
974
DELISTED
Engility Holdings, Inc.
EGL
| $344K | ﹤0.01% |
18,360
-920
| -5% | -$16.5K |
|
975
Starbucks
SBUX
$123B
| $343K | ﹤0.01% |
5,750
-731,641
| -99% | -$42.6M |
|
Similar funds
Dmitry Balyasny's Q1 2016 Portfolio in Review
As of Q1 2016, Dmitry Balyasny held 1,764 positions worth $16.8B, up 17% from $14.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Dmitry Balyasny deployed $2.2B of net new capital in Q1 2016, opening 564 new positions and adding to 341 existing holdings. Its largest new stake was Norfolk Southern: 1,546,641 shares worth $129M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 16% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Teva Pharmaceuticals, an estimated $187M trimmed.
- Dmitry Balyasny's largest Q1 2016 buy was Norfolk Southern: 1,546,641 shares worth $129M.
- Dmitry Balyasny added most to Marathon Petroleum in Q1 2016, an estimated $152M increase.
- Dmitry Balyasny's biggest Q1 2016 reduction was Teva Pharmaceuticals, cutting an estimated $187M.
- Dmitry Balyasny fully exited Union Pacific in Q1 2016, selling an estimated $79.7M.
- Dmitry Balyasny's ten largest holdings make up 12% of its $16.8B portfolio in Q1 2016.
- Dmitry Balyasny opened 564 new positions and closed 526 in Q1 2016.
- Dmitry Balyasny's portfolio value rose 17% quarter-over-quarter to $16.8B.
Based on Balyasny Asset Management's 13F filing for Q1 2016, filed 16 May 2016.